Use of serial changes in biomarkers vs. baseline levels to predict left ventricular remodelling after STEMI.

Roland KlingenbergFranziska HoltkampDimitri GrünAnna FreyValérie JahnsRoland JahnsTobias GassenmaierChristian W HammStefan FrantzTill Keller

Published in: ESC heart failure (2022)

Baseline biomarker levels of hsTnT and ST2 were the strongest predictors of LVEF and LVEDV at 12 months after STEMI. The association of CCN1 with LVEDV and infarct size warrants further study into the underlying pathophysiology of this novel biomarker.

Keyphrases

left ventricular
percutaneous coronary intervention
acute myocardial infarction
st elevation myocardial infarction
st segment elevation myocardial infarction
heart failure
coronary artery disease
acute coronary syndrome
mitral valve
cardiac resynchronization therapy
atrial fibrillation
ejection fraction